Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.4.0.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents [note 4] $ 18,913 $ 34,310
Short-term investments [note 4] 27,201 20,876
Interest receivable 53 111
Prepaid expenses 1,585 1,987
Other current assets 233 14
Total current assets 47,985 57,298
Restricted cash [note 4 and note 7] 272 272
Property and equipment, net 546 602
Other assets 38 37
Total assets 48,841 58,209
Current liabilities:    
Accounts payable 592 1,343
Accrued liabilities other 909 641
Accrued clinical liabilities 8,450 9,966
Accrued compensation 744 1,267
Current portion of long-term obligations [note 7] 51 52
Lease termination liability [note 7] 1,250 1,250
Deferred collaboration revenue [note 3] 2,099 5,040
Warrant liability [note 4 and note 5] 438 1,105
Total current liabilities 14,533 20,664
Long-term obligations, less current portion [note 7] 92 105
Total liabilities $ 14,625 $ 20,769
Commitments and contingencies [note 7]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 29,948,219 and 29,846,991 issued at March 31, 2016 and December 31, 2015, respectively, and 29,914,226 and 29,812,998 outstanding at March 31, 2016 and December 31, 2015, respectively $ 30 $ 29
Additional paid-in capital 212,058 211,590
Accumulated deficit (180,518) (176,811)
Accumulated other comprehensive income 2,646 2,632
Total stockholders' equity 34,216 37,440
Total liabilities and stockholders' equity $ 48,841 $ 58,209